2018
DOI: 10.12688/f1000research.14509.1
|View full text |Cite
|
Sign up to set email alerts
|

The challenges of designing a benchmark strategy for bioinformatics pipelines in the identification of antimicrobial resistance determinants using next generation sequencing technologies

Abstract: Next-Generation Sequencing (NGS) technologies are expected to play a crucial role in the surveillance of infectious diseases, with their unprecedented capabilities for the characterisation of genetic information underlying the virulence and antimicrobial resistance (AMR) properties of microorganisms.  In the implementation of any novel technology for regulatory purposes, important considerations such as harmonisation, validation and quality assurance need to be addressed.  NGS technologies pose unique challeng… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
18
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 26 publications
(18 citation statements)
references
References 77 publications
0
18
0
Order By: Relevance
“…Designing and executing a benchmarking trial offers several challenges. At a recent meeting (October 2017) organized by the European Commission Joint Research Center, the challenges of designing a benchmarking strategy for assessing bioinformatics tools to detect AMR determinants was discussed (65). Here, several challenges were identified, and considerations discussed which included: (1) the origin of the dataset tested; (2) sustainable reference datasets; (3) quality of the test genomes; (4) what determinants to include in a dataset; (5) the, expected result; and (6) performance thresholds.…”
Section: Benchmarking Of Bioinformatics Tools To Detect Antimicrobialmentioning
confidence: 99%
See 1 more Smart Citation
“…Designing and executing a benchmarking trial offers several challenges. At a recent meeting (October 2017) organized by the European Commission Joint Research Center, the challenges of designing a benchmarking strategy for assessing bioinformatics tools to detect AMR determinants was discussed (65). Here, several challenges were identified, and considerations discussed which included: (1) the origin of the dataset tested; (2) sustainable reference datasets; (3) quality of the test genomes; (4) what determinants to include in a dataset; (5) the, expected result; and (6) performance thresholds.…”
Section: Benchmarking Of Bioinformatics Tools To Detect Antimicrobialmentioning
confidence: 99%
“…Ideally, a combination could be applied designing a desired benchmarking dataset to represent real-life scenarios aligned with the test objective (e.g., only focused on extended spectrum β-lactamases). The scope of bacterial species represented can also influence the results (65).…”
Section: Benchmarking Of Bioinformatics Tools To Detect Antimicrobialmentioning
confidence: 99%
“…Regardless of software or the combination of software programs employed, the use of quality control (QC) criteria remains crucial for any laboratory process. Each sequencing methodology has its own QC metrics to ensure the quality of the sequencing data, and this does not enable the use of a single and uniform set of QC parameters [43]. Moreover, different downstream applications would require different levels of QC parameters and metrics, such as SNP analysis from screening resistance/virulence genes, as the former requires greater coverage and sequencing for data analysis than the latter.…”
Section: Challenges Of Sequencing and Data Analysismentioning
confidence: 99%
“…This is however of paramount importance as bioinformatics analysis is inherently part of the evaluation of every step of the entire WGS workflow going from sample isolation, DNA extraction, library preparation, sequencing, to the actual bioinformatics assays. It is therefore imperative to thoroughly validate this step before the other levels of the WGS workflow are evaluated (Angers-Loustau et al, 2018). The bioinformatics analysis acts as the “most common denominator” between these different steps, allowing to compare and evaluate their performance.…”
Section: Introductionmentioning
confidence: 99%